(Q41640876)

5 October 2017

1 reference

title

Tumour identification using radiopharmaceuticals (English)

1 reference

5 October 2017

Britton KE

1

1 reference

5 October 2017

Granowska M

series ordinal

2

1 reference

5 October 2017

publication date

1 October 1997

1 reference

5 October 2017

1 reference

5 October 2017

volume

52

1 reference

5 October 2017

issue

10

1 reference

5 October 2017

page(s)

731-738

1 reference

Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

201Tl single photon emission tomography in the evaluation of residual and recurrent astrocytoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Experimental evaluation of the usefulness of 201Tl-chloride scintigraphy for monitoring radiotherapeutic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

The use of 99mTc-MIBI scanning in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Peroperative radioimmunodetection of ovarian carcinoma using a hand-held gamma detection probe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

A prospective study of the use of 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Breast cancer 99mTc SM3 radioimmunoscintigraphy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radionuclide therapy revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

131I-MIBG as a first-line treatment in high-risk neuroblastoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

7 January 2021

inferred from DOI database lookup

Radiolabelled monoclonal antibodies in oncology. I. Technical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

7 January 2021

inferred from DOI database lookup

Radiolabelled monoclonal antibodies in oncology. II. Clinical applications in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2897%2980150-X

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0009-9260(97)80150-X

1 reference

release_vpxtnnyerzbdvdak6bifehvwoq

5 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vpxtnnyerzbdvdak6bifehvwoq

24 November 2022

mapped directly with Wikidata item

1 reference